ADC Pharmacokinetics and Clinical Pharmacology Summit
Evvnt Promotion / evvnt
Archive
08.10.2024 - 10.10.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 am to 5:00 pm
Conference themes
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Scientific Society
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Enquiries and Registration:
https://go.evvnt.com/2465910-1?pid=4832
Ms. Abigail Cox
Health Services
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
